Reports for IRBESARTAN
Ingredient
IRBESARTAN
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AVAPRO | 300MG | TABLET | Anticipated shortage | 2022-08-02 | 2022-08-02 | 165911 |
| AVALIDE | 12.5MG 300MG | TABLET | Actual shortage | 2022-04-14 | 2022-06-27 | 158890 |
| AVAPRO | 75MG | TABLET | Actual shortage | 2021-12-16 | 2022-06-27 | 151325 |
| AVAPRO | 300MG | TABLET | Resolved | 2021-12-02 | 2022-06-09 | 150376 |
| AVAPRO | 150MG | TABLET | Resolved | 2022-01-21 | 2022-06-09 | 153358 |
| PMS-IRBESARTAN-HCTZ | 12.5MG 300MG | TABLET | Actual shortage | 2021-11-15 | 2021-11-15 | 149254 |
| SANDOZ IRBESARTAN HCT | 25MG 300MG | TABLET | Resolved | 2021-10-19 | 2021-10-26 | 147570 |
| JAMP-IRBESARTAN | 75MG | TABLET | Actual shortage | 2019-10-11 | 2021-09-16 | 96162 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2020-03-10 | 2021-09-14 | 108344 |
| IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Resolved | 2020-01-20 | 2021-09-14 | 103710 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143959 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143956 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143952 |
| TARO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80028 |
| TARO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80025 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65074 |